← FDA Drug Approvals (Drugs@FDA)

CEFIXIME

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2021-02-19

Drug application

FDA Application #

ANDA211775

Application type

Abbreviated New Drug Application (Generic)

Brand name

CEFIXIME

Generic name

Cefixime

Active ingredients

CEFIXIME

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

ALKEM LABS LTD

First approval

2021-02-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown